$360B Women's Health Ghost Market Report

The Ghost Market Report shines a spotlight on the massive, yet overlooked opportunities within women's health—a space we've termed the "Ghost Market." It explores critical healthcare gaps affecting millions of women, highlighting where current solutions are insufficient or entirely absent. Our analysis identifies key areas ripe for innovation and investment, aiming to direct funding and attention toward impactful novel solutions in women's health.

Please complete the form below to receive this Ghost Market Report:

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Top 10 Deals of 2025: Remedy Meds to Acquire Thirty Madison for $500M

Each year, Amboy Street publishes a Top 10 Deals of the Year series highlighting the most significant transactions in women’s health. This week, we spotlight Remedy Meds’ $500M acquisition of Thirty Madison in women’s digital consumer health.

Top 10 Deals of 2025: KKR acquires Karo Healthcare for $3B

This week we highlight a notable transaction in consumer health: EQT sells Karo Healthcare to KKR for $3B.

Amboy Street Co-Leads Nest Health's Series A with 8VC and BVF

Amboy Street Ventures invests in Nest Health's $22.5M+ Series A round to advance value-based whole-family care for underserved populations.

Top 10 Deals of 2025: BillionToOne’s $4.4B IPO

This week we dig into a standout moment for women’s health diagnostics: BillionToOne’s Nasdaq listing, which priced above range and signals a tentative thaw in the healthcare IPO market.

Top 10 Deals of 2025: TPG & Blackstone to Acquire Hologic for $18.3B

This week we unpack a watershed deal in women’s health: Blackstone and TPG’s agreement to take Hologic private. We examine what the transaction suggests about the broader reopening of healthcare dealmaking and what that means for women’s health diagnostics, devices, and services innovation.

LGBTQ+ Mental Health Startup Allswell Raises $1.3M to Address Gaps in Care

Amboy Street Ventures invests in Allswell’s $1.3M pre-seed round to advance accessible, culturally competent behavioral healthcare for the LGBTQ+ population.

Top 10 Deals of 2025: Hinge Health IPOs, Breaking the Stalemate

This week we unpack one of the first major IPOs in digital health, Hinge Health’s debut.

Top 10 Deals of 2025: Breast Cancer Therapeutic Acquired for $2.5B by Eli Lilly

Every year, Amboy Street publishes a series of blogs highlighting ten notable women’s health deals from the past twelve months that reflect the latest trends and major successes.

Amboy Street Invests in Juniper Genomics’ $4.6M Seed Round

Amboy Street Ventures is pleased to announce its participation in the $4.6 million seed round for Juniper Genomics, a company transforming care in IVF with the world’s first embryo screening test powered by whole-genome and transcriptome sequencing.

Fast track our industry.
Get in touch today.